Document is current
Any future updates will be listed below
-
Authors
Rosen, Elias P. https://orcid.org/0000-0001-5531-7281
Bondoc, Stephen
Bailón, Lucía https://orcid.org/0000-0001-7277-9314
Blay, Lidia
Caballero, Albert
García-Guerrero, Maria C.
Puertas, Maria C. https://orcid.org/0000-0002-6750-2318
Moraes-Cardoso, Igor https://orcid.org/0000-0003-1011-8849
Vazquez-Escobales, Andrea
Blanco, Julià https://orcid.org/0000-0002-2225-0217
Mothe, Beatriz https://orcid.org/0000-0001-9975-407X
Kashuba, Angela DM
Estes, Jacob D. https://orcid.org/0000-0002-9652-6394
Martinez-Picado, Javier https://orcid.org/0000-0002-4916-2129
Molto, Jose https://orcid.org/0000-0003-4564-1963
,
Rosen, Elias P.
Bondoc, Stephen
Bailón, Lucía
Blay, Lidia
Caballero, Albert
García-Guerrero, Maria C.
Puertas, Maria C.
Moraes-Cardoso, Igor
Vazquez-Escobales, Andrea
Blanco, Julià
Mothe, Beatriz
Kashuba, Angela DM
Estes, Jacob D.
Martinez-Picado, Javier
Molto, Jose
Julian, Joan Francesc
Alarcón-Soto, Yovaninna
Benet, Susana
Miranda, Cristina
Nieto, Aroa
Paredes, Roger
Rivero, Angel
Sabato, Sofia
Aparicio, Ester
Brander, Christian
Marfil, Silvia
Olvera, Alex
Pradenas, Edwards
Urrea, Victor
Desyaterik, Yury
White, Nicole
- License Information
-
More Information
Article History
Received: 4 May 2026
Accepted: 15 September 2026
First Online: 2 October 2026
Ethics
Competing interests: M.C.P. has received institutional research funding from Gilead Sciences. J.B. has received institutional research funding from MSD, HIPRA, has been CEO and founder of ALbaJuna Therapeutics, and has served as consultant for NESAPOR and HIPRA. BM reports consultancy personal fees from AELIX Therapeutics SL, MSD and AbbVie, as well as speakers’ fees from Gilead, Janssen, HIPRA and ViiV Healthcare, outside the submitted work. J.M.P. has received research funding, consultancy fees and lecture sponsorships from and has served on advisory boards for various laboratories (MSD, Gilead Sciences, ViiV Healthcare). J.M. has received research funding, consultancy fees and lecture sponsorships from and has served on advisory boards for various laboratories (MSD, Gilead Sciences, ViiV Healthcare, Johnson & Johnson). All other authors report no potential conflicts.
